130 related articles for article (PubMed ID: 21040744)
21. Role of allograft inflammatory factor-1 in bleomycin-induced lung fibrosis.
Nagahara H; Seno T; Yamamoto A; Obayashi H; Inoue T; Kida T; Nakabayashi A; Kukida Y; Fujioka K; Fujii W; Murakami K; Kohno M; Kawahito Y
Biochem Biophys Res Commun; 2018 Jan; 495(2):1901-1907. PubMed ID: 29225172
[TBL] [Abstract][Full Text] [Related]
22. Cutaneous gene expression by DNA microarray in murine sclerodermatous graft-versus-host disease, a model for human scleroderma.
Zhou L; Askew D; Wu C; Gilliam AC
J Invest Dermatol; 2007 Feb; 127(2):281-92. PubMed ID: 16917493
[TBL] [Abstract][Full Text] [Related]
23. Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis.
Distler JH; Jüngel A; Kowal-Bielecka O; Michel BA; Gay RE; Sprott H; Matucci-Cerinic M; Chilla M; Reich K; Kalden JR; Müller-Ladner U; Lorenz HM; Gay S; Distler O
Arthritis Rheum; 2005 Mar; 52(3):856-64. PubMed ID: 15751077
[TBL] [Abstract][Full Text] [Related]
24. FGF-2, IL-1beta and TGF-beta regulate fibroblast expression of S100A8.
Rahimi F; Hsu K; Endoh Y; Geczy CL
FEBS J; 2005 Jun; 272(11):2811-27. PubMed ID: 15943814
[TBL] [Abstract][Full Text] [Related]
25. Blockade of Syk ameliorates the development of murine sclerodermatous chronic graft-versus-host disease.
Le Huu D; Kimura H; Date M; Hamaguchi Y; Hasegawa M; Hau KT; Fujimoto M; Takehara K; Matsushita T
J Dermatol Sci; 2014 Jun; 74(3):214-21. PubMed ID: 24679982
[TBL] [Abstract][Full Text] [Related]
26. A significant role of stromal fibroblasts in rapidly progressive dry eye in patients with chronic GVHD.
Ogawa Y; Yamazaki K; Kuwana M; Mashima Y; Nakamura Y; Ishida S; Toda I; Oguchi Y; Tsubota K; Okamoto S; Kawakami Y
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):111-9. PubMed ID: 11133855
[TBL] [Abstract][Full Text] [Related]
27. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.
Chen G; Wu D; Wang Y; Cen J; Feng Y; Sun A; Tang X; Chang H; Zhu Z
Eur J Haematol; 2008 Sep; 81(3):226-35. PubMed ID: 18573173
[TBL] [Abstract][Full Text] [Related]
28. Allograft inflammatory factor-1 and tumor necrosis factor single nucleotide polymorphisms in systemic sclerosis.
Otieno FG; Lopez AM; Jimenez SA; Gentiletti J; Artlett CM
Tissue Antigens; 2007 Jun; 69(6):583-91. PubMed ID: 17498268
[TBL] [Abstract][Full Text] [Related]
29. Mast cells in murine graft-versus-host disease: a model of immunologically induced fibrosis.
Choi KL; Claman HN
Immunol Ser; 1989; 46():641-51. PubMed ID: 2488873
[No Abstract] [Full Text] [Related]
30. Increased CD40 expression in skin fibroblasts from patients with systemic sclerosis (SSc): role of CD40-CD154 in the phenotype of SSc fibroblasts.
Fukasawa C; Kawaguchi Y; Harigai M; Sugiura T; Takagi K; Kawamoto M; Hara M; Kamatani N
Eur J Immunol; 2003 Oct; 33(10):2792-800. PubMed ID: 14515263
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation.
Dander E; Balduzzi A; Zappa G; Lucchini G; Perseghin P; Andrè V; Todisco E; Rahal D; Migliavacca M; Longoni D; Solinas G; Villa A; Berti E; Mina PD; Parma M; Allavena P; Biagi E; Rovelli A; Biondi A; D'Amico G
Transplantation; 2009 Dec; 88(11):1261-72. PubMed ID: 19996925
[TBL] [Abstract][Full Text] [Related]
32. A CD40-CD154 interaction in tissue fibrosis.
Kawai M; Masuda A; Kuwana M
Arthritis Rheum; 2008 Nov; 58(11):3562-73. PubMed ID: 18975310
[TBL] [Abstract][Full Text] [Related]
33. IL-6 blockade attenuates the development of murine sclerodermatous chronic graft-versus-host disease.
Le Huu D; Matsushita T; Jin G; Hamaguchi Y; Hasegawa M; Takehara K; Fujimoto M
J Invest Dermatol; 2012 Dec; 132(12):2752-61. PubMed ID: 22810302
[TBL] [Abstract][Full Text] [Related]
34. Decreased susceptibility to Fas-induced apoptosis of systemic sclerosis dermal fibroblasts.
Santiago B; Galindo M; Rivero M; Pablos JL
Arthritis Rheum; 2001 Jul; 44(7):1667-76. PubMed ID: 11465719
[TBL] [Abstract][Full Text] [Related]
35. Histological assessment of the sclerotic graft-versus-host response in the humanized RAG2-/-γc-/- mouse model.
Hogenes MC; van Dorp S; van Kuik J; Monteiro FR; ter Hoeve N; van Dijk MR; Martens AC; de Weger RA
Biol Blood Marrow Transplant; 2012 Jul; 18(7):1023-35. PubMed ID: 22579931
[TBL] [Abstract][Full Text] [Related]
36. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
[TBL] [Abstract][Full Text] [Related]
37. Cloning and characterization of allograft inflammatory factor-1: a novel macrophage factor identified in rat cardiac allografts with chronic rejection.
Utans U; Arceci RJ; Yamashita Y; Russell ME
J Clin Invest; 1995 Jun; 95(6):2954-62. PubMed ID: 7769138
[TBL] [Abstract][Full Text] [Related]
38. Latency-associated peptide prevents skin fibrosis in murine sclerodermatous graft-versus-host disease, a model for human scleroderma.
Zhang Y; McCormick LL; Gilliam AC
J Invest Dermatol; 2003 Oct; 121(4):713-9. PubMed ID: 14632186
[TBL] [Abstract][Full Text] [Related]
39. Chemokine expression by systemic sclerosis fibroblasts: abnormal regulation of monocyte chemoattractant protein 1 expression.
Galindo M; Santiago B; Rivero M; Rullas J; Alcami J; Pablos JL
Arthritis Rheum; 2001 Jun; 44(6):1382-6. PubMed ID: 11407698
[TBL] [Abstract][Full Text] [Related]
40. Autocrine activation by interleukin 1alpha induces the fibrogenic phenotype of systemic sclerosis fibroblasts.
Kawaguchi Y; McCarthy SA; Watkins SC; Wright TM
J Rheumatol; 2004 Oct; 31(10):1946-54. PubMed ID: 15468358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
